Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela M Peck

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|June 19, 2004
Biotinylated geldanamycinRandell C Clevenger, Joseph M Raibel, Angela M Peck, et al.
International Journal of Peptide Research and Therapeutics|December 4, 2009
Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide InteractionsJane V Aldrich, Vivek Kumar, Bhaswati Dattachowdhury, et al.
Journal of Medicinal Chemistry|September 26, 2014
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2Dean Y Maeda, Angela M Peck, Aaron D Schuler, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2015
Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding modelDean Y Maeda, Angela M Peck, Aaron D Schuler, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|June 19, 2004
Biotinylated geldanamycinRandell C Clevenger, Joseph M Raibel, Angela M Peck, et al.
International Journal of Peptide Research and Therapeutics|December 4, 2009
Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide InteractionsJane V Aldrich, Vivek Kumar, Bhaswati Dattachowdhury, et al.
Journal of Medicinal Chemistry|September 26, 2014
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2Dean Y Maeda, Angela M Peck, Aaron D Schuler, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2015
Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding modelDean Y Maeda, Angela M Peck, Aaron D Schuler, et al.
Pageof 1